2 HEALTHCARE Middle East Respiratory Syndrome (MERS) infection Since it first emerged in the Arabian Peninsula is the year 2012, Middle East Respiratory Syndrome (MERS) has been drawing significant public attention. There has been considerable research going on for better understanding the nature of the virus, the impact on humans and how it can be prevented. The infection in humans occurs as a viral respiratory illness that is caused due to Middle East Respiratory Syndrome Coronavirus (MERS-CoV). One must note that MERS-CoV is drastically dissimilar from any other such isolated previously. Some individuals might be developing mild or no symptoms; however most of the infected individuals develop severe respiratory illness. The major complications are cough, high fever and shortness of breadth. Other health impacts include nausea, diarrhea, gastrointestinal symptoms and even kidney failure. Mortality rate for this disease has been significant (Memish et al. 2014). The mode of transmission of the infectious agent, as perceived, from person to person, is respiratory secretions. The specific way in which the virus spreads is not understood in a clear manner (de Groot et al., 2013). The researchers point out that there is no available vaccine at the present that can prevent the infection. CDC advises protection against this particular infection through adherence to guidelines for all respiratory diseases such as hand sanitisation, avoidance of direct contact with sick individuals and disinfection of touched surfaces. CDC further recommends that travel plans are to be changed due to MERS. Special precautions are to be maintained by travellers who stay in regions where incidences of the infection have been reported. Individuals travelling to countries in or near the Arabian Peninsula are required to be given primary healthcare services as the recommendations of
3 HEALTHCARE CDC to control the further spread of the infection. Monitoring of cases closely is important for tracking suspected or confirmed cases (Memish et al. 2013).
4 HEALTHCARE References de Groot, R.J., Baker, S.C., Baric, R.S., Brown, C.S., Drosten, C., Enjuanes, L., Fouchier, R.A., Galiano, M., Gorbalenya, A.E., Memish, Z.A. and Perlman, S., 2013. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.Journal of virology,87(14), pp.7790-7792. Memish, Z.A., Al-Tawfiq, J.A., Assiri, A., AlRabiah, F.A., Al Hajjar, S., Albarrak, A., Flemban, H., Alhakeem, R.F., Makhdoom, H.Q., Alsubaie, S. and Al-Rabeeah, A.A., 2014. Middle East respiratory syndrome coronavirus disease in children.The Pediatric infectious disease journal,33(9), pp.904-906. Memish, Z.A., Zumla, A.I., Al-Hakeem, R.F., Al-Rabeeah, A.A. and Stephens, G.M., 2013. Family cluster of Middle East respiratory syndrome coronavirus infections.New England Journal of Medicine,368(26), pp.2487-2494.